In its recent report,1 the Institute of Medicine (IOM) urged as its first recommendation that cancer survivorship be recognized as “a distinct phase of cancer care.” The rationale for this is that until recently cancer survivorship has been relatively neglected in clinical practice, advocacy, and research. By virtue of their sheer numbers and the expected rate of growth of this population, however, the quality of the medical care cancer survivors receive is an increasingly important public health issue. Part of the problem is that there has not been a unifying identity for these patients and the challenges they face. The IOM report strove to address this by defining and highlighting a constellation of long-term and late effects that result from having had cancer treatment: issues around surveillance for and prevention of recurrence and second cancers, long-term and late effects of treatment, psychological sequelae, and social problems such as employment and insurance concerns.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Institute of Medicine. From cancer patient to cancer survivor: Lost in transition. National Academies Press: Washington, 2005.Google Scholar
  2. 2.
    Makaryus, A.N., and Friedman, E.A. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin. Proc. 2005; 80: 991–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Geiger, A.M., Fischberg, G.M., Chen, W., and Bernstein, L. Stroke risk and tamoxifen therapy for breast cancer. J. Natl. Cancer Inst. 2004; 96: 1528–36.PubMedGoogle Scholar
  4. 4.
    Desch, C.E., Benson, A.B., Somerfield, M.R., et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J. Clin. Oncol. 2005; 23: 8512–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Johnson, F.E. Overview. In: Johnson, F.E., and Virgo, K.S., (eds.). Cancer Patient Follow-Up. Mosby: St. Louis, 1997, p. 4.Google Scholar
  6. 6.
    Bast, R.C.J., Ravdin, P., Hayes, D.F., et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 2001; 19: 1865–78.PubMedGoogle Scholar
  7. 7.
    Smith, T.J., Davidson, N.E., Schapira, D.V., et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J. Clin. Oncol. 1999; 17: 1080–2.PubMedGoogle Scholar
  8. 8.
    Elston, L.J., Simpkins, J., Schultz, L., et al. Routine surveillance care after cancer treatment with curative intent. Med. Care 2005; 43: 592–9.CrossRefGoogle Scholar
  9. 9.
    Stiggelbout, A.M., de Haes, J.C., Vree, R., et al. Follow-up of colorectal cancer patients: Quality of life and attitudes towards follow-up. Br. J. Cancer 1997; 75: 914–20.PubMedGoogle Scholar
  10. 10.
    Grunfeld, E., Mant, D., Yudkin, P., et al. Routine follow-up of breast cancer in primary care: Randomised trial. BMJ 1996; 313: 665–9.PubMedGoogle Scholar
  11. 11.
    The GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994; 271: 1587–92.CrossRefGoogle Scholar
  12. 12.
    Kjeldsen, B.J., Thorsen, H., Whalley, D., and Kronborg, O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand. J. Gastroenterol. 1999; 34: 509–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Lampic, C., Wennberg, A., Schill, J.E., Brodin, O., Glimelius, B., and Sjoden, P.O. Anxiety and cancer-related worry of cancer patients at routine follow-up visits. Acta Oncol. 1994; 33: 119–25.PubMedGoogle Scholar
  14. 14.
    Loprinzi, C.L., Hayes, D., and Smith, T. Doc, shouldn't we be getting some tests? J. Clin. Oncol. 2000; 18: 2345–8.PubMedGoogle Scholar
  15. 15.
    Muss, H.B., Tell, G.S., Case, L.D., Robertson, P., and Atwell, B.M. Perceptions of follow-up care in women with breast cancer. Am. J. Clin. Oncol. 1991; 14: 55–9.PubMedGoogle Scholar
  16. 16.
    Fong, Y., Cohen, A.M., Fortner, J.G., et al. Liver resection for colorectal metastases. J. Clin.l Oncol. 1997; 15: 938–46.Google Scholar
  17. 17.
    NIH Consensus Development Panel on Ovarian Cancer. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. JAMA 1995; 273: 491–7.CrossRefGoogle Scholar
  18. 18.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. J. Clin. Oncol. 1992; 10: 904–11.Google Scholar
  19. 19.
    Grunfeld, E., Levine, M.N., Julian, J.A., et al. Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care. J. Clin. Oncol. 2006 Feb 20; 24(6): 848–55.CrossRefGoogle Scholar
  20. 20.
    Weeks, J.C., Yeap, B.Y., Canellos, G.P., and Shipp, M.A. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J. Clin. Oncol. 1991; 9: 1196–203.PubMedGoogle Scholar
  21. 21.
    Virgo, K.S., and Johnson, F.E. Costs of surveillance after potentially curative treatment for cancer. In: Johnson, F.E., and Virgo, K.S. (eds.). Cancer Patient Follow-Up. Mosby: St. Louis, 1997, p. 45.Google Scholar
  22. 22.
    Drummond, M.F., Stoddart, G.L., and Torrance, G.W. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press: Oxford, 1987.Google Scholar
  23. 23.
    Renehan, A.G., Egger, M., Saunders, M.P., and O'Dwyer, S.T. Impact on survival of intensive follow up after curative resection for colorectal cancer: Systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Donaldson, S.S., Hancock, S.L., and Hoppe, R.T. The Janeway lecture. Hodgkin's disease—finding the balance between cure and late effects. Cancer J. Sci. Am. 1999; 5: 325–33.PubMedGoogle Scholar
  25. 25.
    Shimozuma, K., Ganz, P.A., Petersen, L., and Hirji, K. Quality of life in the first year after breast cancer surgery: Rehabilitation needs and patterns of recovery. Breast Cancer Res. Treat. 1999; 56: 45–57.PubMedCrossRefGoogle Scholar
  26. 26.
    Dales, R.E., Dionne, G., Leech, J.A., Lunau, M., and Schweitzer, I. Preoperative prediction of pulmonary complications following thoracic surgery. Chest 1993; 104: 155–9.PubMedGoogle Scholar
  27. 27.
    Valji, A.M., Maziak, D.E., Shamji, F.M., and Matzinger, F.R. Postpneumonectomy syndrome: Recognition and management. Chest 1998; 114: 1766–9.PubMedGoogle Scholar
  28. 28.
    Ries, L.A.G., Harkins, D., Krapcho, M., Mariotto, A., Miller, B.A., Feuer, E.J., Clegg, L., Eisner, M.P., Horner, M.J., Howlader, N., Hayat, M., Hankey, B.F., and Edwards, B.K. (eds). SEER Cancer Statistics Review, 1975–2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975–2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006.Google Scholar
  29. 29.
    Leisenring, W., Friedman, D.L., Flowers, M.E., Schwartz, J.L., and Deeg, H.J. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. J. Clin. Oncol. 2006; 24: 1119–26.PubMedCrossRefGoogle Scholar
  30. 30.
    Komaki, R., Meyers, C.A., Shin, D.M., et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1995; 33: 179–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Burstein, H.J., and Winer, E.P. Primary care for survivors of breast cancer. N. Engl. J. Med. 2000; 343: 1086–94.PubMedCrossRefGoogle Scholar
  32. 32.
    Mehta, V. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction, and prevention. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63: 5–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Borst, G.R., De Jaeger, K., Belderbos, J.S., Burgers, S.A., and Lebesque, J.V. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int. J. Radiat. Oncol. Biol. Phys. 2005; 62: 639–44.PubMedCrossRefGoogle Scholar
  34. 34.
    Adams, M.J., Lipsitz, S.R., Colan, S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J. Clin. Oncol. 2004; 22: 3139–48.PubMedCrossRefGoogle Scholar
  35. 35.
    Giordano, S.H., Kuo, Y.F., Freeman, J.L., Buchholz, T.A., Hortobagyi, G.N., and Goodwin, J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J. Natl. Cancer Inst. 2005; 97: 419–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Cuzick, J. Radiotherapy for breast cancer. J. Natl. Cancer. Inst. 2005; 97: 406–7.PubMedGoogle Scholar
  37. 37.
    Bowers, D.C., McNeil, D.E., Liu, Y., et al. Stroke as a late treatment effect of Hodgkin's disease: A report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 2005; 23: 6508–15.PubMedCrossRefGoogle Scholar
  38. 38.
    Theodoulou, M., and Seidman, A.D. Cardiac effects of adjuvant therapy for early breast cancer. Semin. Oncol. 2003; 30: 730–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Miller, D.C., Sanda, M.G., Dunn, R.L., et al. Long-term outcomes among localized prostate cancer survivors: Health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J. Clin. Oncol. 2005; 23: 2772–80.PubMedCrossRefGoogle Scholar
  40. 40.
    Lobo, R.A. Potential options for preservation of fertility in women. N. Engl. J. Med. 2005; 353: 64–73.PubMedCrossRefGoogle Scholar
  41. 41.
    Wallace, W.H., Thomson, A.B., Saran, F., and Kelsey, T.W. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int. J. Radiat. Oncol. Biol. Phys. 2005; 62: 738–44.PubMedCrossRefGoogle Scholar
  42. 42.
    DeSantis, M., Albrecht, W., Holtl, W., and Pont, J. Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer. Int. J. Cancer. 1999; 83: 864–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Robinson, J.W., Moritz, S., and Fung, T. Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 1063–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Baxter, N.N., Habermann, E.B., Tepper, J.E., Durham, S.B., and Virnig, B.A. Risk of pelvic fractures in older women following pelvic irradiation. JAMA 2005; 294: 2587–93.PubMedCrossRefGoogle Scholar
  45. 45.
    Turner, S.L., Tiver. K.W., and Boyages. S.C. Thyroid dysfunction following radiotherapy for head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 279–83.PubMedCrossRefGoogle Scholar
  46. 46.
    Jereczek-Fossa, B.A., Alterio, D., Jassem, J., Gibelli, B., Tradati, N., and Orecchia, R. Radiotherapy-induced thyroid disorders. Cancer Treat. Rev. 2004; 30: 369–84.PubMedCrossRefGoogle Scholar
  47. 47.
    Rose, S.R. Cranial irradiation and central hypothyroidism. Trends Endocrinol. Metab. 2001; 12: 97–104.PubMedCrossRefGoogle Scholar
  48. 48.
    Ron, E., Lubin, J.H., Shore, R.E., et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat. Res. 1995; 141: 259–77.PubMedCrossRefGoogle Scholar
  49. 49.
    Tannock, I.F., Ahles, T.A., Ganz, P.A., and Van Dam, F.S. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. J. Clin. Oncol. 2004; 22: 2233–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Wefel, J.S., Lenzi, R., Theriault, R., Buzdar, A.U., Cruickshank, S., and Meyers, C.A. ‘Chemobrain’ in breast carcinoma?: A prologue. Cancer 2004; 101: 466–75.PubMedCrossRefGoogle Scholar
  51. 51.
    Nuver, J., Smit, A.J., van der Meer, J., et al. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J. Clin. Oncol. 2005; 23: 9130–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Loprinzi, C.L., Sloan, J.A., Perez, E.A., et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J. Clin. Oncol. 2002; 20: 1578–83.PubMedCrossRefGoogle Scholar
  53. 53.
    Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M., and Hood, N. Risk of menopause during the first year after breast cancer diagnosis. J. Clin. Oncol. 1999; 17: 2365–70.PubMedGoogle Scholar
  54. 54.
    Aisner, J., Wiernik, P.H., and Pearl, P. Pregnancy outcome in patients treated for Hodgkin's disease. J. Clin. Oncol. 1993; 11: 507–12.PubMedGoogle Scholar
  55. 55.
    Howell, S.J., and Shalet, S.M. Spermatogenesis after cancer treatment: Damage and recovery. J. Natl. Cancer. Inst. Monogr. 2005; 34: 12–17.PubMedCrossRefGoogle Scholar
  56. 56.
    Ganz, P.A., Rowland, J.H., Desmond, K., Meyerowitz, B.E., and Wyatt, G.E. Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. J. Clin. Oncol. 1998; 16: 501–14.PubMedGoogle Scholar
  57. 57.
    Ganz, P.A., Desmond, K.A., Belin, T.R., Meyerowitz, B.E., and Rowland, J.H. Predictors of sexual health in women after a breast cancer diagnosis. J. Clin. Oncol. 1999; 17: 2371–80.PubMedGoogle Scholar
  58. 58.
    Rowland, J.H., Desmond, K.A., Meyerowitz, B.E., Belin, T.R., Wyatt, G.E., and Ganz, P, A. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J. Natl. Cancer Inst. 2000; 92: 1422–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Fallowfield, L., Fleissig, A., Edwards, R., et al. Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials. J. Clin. Oncol. 2001; 19: 1885–92.PubMedGoogle Scholar
  60. 60.
    Mandelblatt, J., Figueiredo, M., and Cullen, J. Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want? Health Qual. Life Outcomes 2003; 1: 45.PubMedCrossRefGoogle Scholar
  61. 61.
    Ganz, P.A., Desmond, K.A., Leedham, B., Rowland, J.H., Meyerowitz, B.E., and Belin, T.R. Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J. Natl. Cancer Inst. 2002; 94: 39–49.PubMedGoogle Scholar
  62. 62.
    Krupski, T.L., Smith, M.R., Lee, W.C., et al. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy. Cancer 2004; 101: 541–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Ramaswamy, B., and Shapiro, C.L. Osteopenia and osteoporosis in women with breast cancer. Semin. Oncol. 2003; 30: 763–75.PubMedCrossRefGoogle Scholar
  64. 64.
    Mackey, J.R., and Joy, A.A. Skeletal health in postmenopausal survivors of early breast cancer. Int. J. Cancer. 2005; 114: 1010–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Hillner, B.E., Ingle, J.N., Chlebowski, R.T., et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J. Clin. Oncol. 2003; 21: 4042–57.PubMedCrossRefGoogle Scholar
  66. 66.
    Sleijfer, S. Bleomycin-induced pneumonitis. Chest 2001; 120: 617–24.PubMedCrossRefGoogle Scholar
  67. 67.
    Moroso, M.J., and Blair, R.L. A review of cis-platinum ototoxicity. J. Otolaryngol. 1983; 12: 365–9.PubMedGoogle Scholar
  68. 68.
    Ganz, P.A., Kwan, L., Stanton, A.L., et al. Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. J. Natl. Cancer Inst. 2004; 96: 376–87.PubMedGoogle Scholar
  69. 69.
    Ramsey, S.D., Berry, K., Moinpour, C., Giedzinska, A., and Andersen, M.R. Quality of life in long term survivors of colorectal cancer. Am. J. Gastroenterol. 2002; 97: 1228–34.PubMedCrossRefGoogle Scholar
  70. 70.
    Kornblith, A.B., and Ligibel, J. Psychosocial and sexual functioning of survivors of breast cancer. Semin. Oncol. 2003; 30: 799–813.PubMedCrossRefGoogle Scholar
  71. 71.
    Lee-Jones, C., Humphris, G., Dixon, R., and Hatcher, M.B. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997; 6: 95–105.PubMedCrossRefGoogle Scholar
  72. 72.
    Sprangers, M.A., Taal, B.G., Aaronson, N.K., and te, V.A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis. Colon Rectum 1995; 38: 361–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Kornblith, A.B., Herndon, J.E., Weiss, R.B., et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003; 98: 679–89.PubMedCrossRefGoogle Scholar
  74. 74.
    Gore, J.L., Krupski, T., Kwan, L., Maliski, S., and Litwin, M.S. Partnership status influences quality of life in low-income, uninsured men with prostate cancer. Cancer 2005; 104: 191–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Manne, S.L. Prostate cancer support and advocacy groups: Their role for patients and family members. Semin. Urol. Oncol. 2002; 20: 45–54.PubMedCrossRefGoogle Scholar
  76. 76.
    Sapp, A.L., Trentham-Dietz, A., Newcomb, P.A., Hampton, J.M., Moinpour, C.M., and Remington, P.L. Social networks and quality of life among female long-term colorectal cancer survivors. Cancer 2003; 98: 1749–58.PubMedCrossRefGoogle Scholar
  77. 77.
    Lepore, S.J., Helgeson, V.S., Eton, D.T., and Schulz, R. Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions. Health Psychol. 2003; 22: 443–52.PubMedCrossRefGoogle Scholar
  78. 78.
    Kroenke, C.H., Rosner, B., Chen, W.Y., Kawachi, I., Colditz, G.A., and Holmes, M.D. Functional impact of breast cancer by age at diagnosis. J. Clin. Oncol. 2004; 22: 1849–56.PubMedCrossRefGoogle Scholar
  79. 79.
    Eton, D.T., Lepore, S.J., and Helgeson, V.S. Early quality of life in patients with localized prostate carcinoma: An examination of treatment-related, demographic, and psychosocial factors. Cancer 2001; 92: 1451–9.PubMedCrossRefGoogle Scholar
  80. 80.
    de Jong, N., Courtens, A.M., Abu-Saad, H.H., and Schouten, H.C. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nurs. 2002; 25: 283–97.PubMedCrossRefGoogle Scholar
  81. 81.
    Ganz, P.A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M.L., and Petersen, L. Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Res. Treat. 1996; 38: 183–99.PubMedCrossRefGoogle Scholar
  82. 82.
    Wolff, S.N., Nichols, C., Ulman, D., et al. Survivorship: An unmet need of the patient the cancer—Implications of a survey of the Lance Armstrong Foundation. Proc. Am. Soc. Clin. Oncol. 2005. (Abstract 6032).Google Scholar
  83. 83.
    Ederer, F., Cutler, S.J., Goldenberg, I.S., and Eisenberg, H. Causes of death among long-term survivors from breast cancer in Connecticut. J. Natl. Cancer Inst. 1963; 30: 933–47.Google Scholar
  84. 84.
    Mandel, J.S., Bond, J.H., Church, T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 1993; 328: 1365–71.PubMedCrossRefGoogle Scholar
  85. 85.
    Ganz, P.A. A teachable moment for oncologists: Cancer survivors, 10 million strong and growing! J. Clin. Oncol. 2005; 23: 5458–60.PubMedCrossRefGoogle Scholar
  86. 86.
    Earle, C.C., Burstein, H.J., Winer, E.P., and Weeks, J.C. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J. Clin. Oncol. 2003; 21: 1447–51.PubMedCrossRefGoogle Scholar
  87. 87.
    Earle, C.C., and Neville, B.A. Underuse of necessary care among elderly colorectal cancer survivors. Cancer 2004; 101: 1712–19.PubMedCrossRefGoogle Scholar
  88. 88.
    American Society of Clinical Oncology. Status of the medical oncology workforce. J. Clin. Oncol. 1996; 14: 2612–21.Google Scholar
  89. 89.
    Miedema, B., MacDonald, I., and Tatemichi, S. Cancer follow-up care. Patients' perspectives. Can. Fam. Physician 2003; 49: 890–95.PubMedGoogle Scholar
  90. 90.
    Woodwell, D.A., and Cherry, D.K. National Ambulatory Medical Care Survey: 2002 summary. Adv. Data 2004; 1–44.Google Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Craig C. Earle

There are no affiliations available

Personalised recommendations